Araştırma Makalesi
BibTex RIS Kaynak Göster

Tip 2 diabetes mellitusu olan Türk yetişkinlerde tamamlayıcı ve alternatif tıp kullanımı ve öz-etkililik düzeyi

Yıl 2019, Cilt: 44 Sayı: 2, 309 - 318, 30.06.2019
https://doi.org/10.17826/cumj.441296

Öz

Amaç:  Bu çalışma Tip 2 diabetes mellitus’u olan bireylerin kan glikoz kontrolünde
uyguladıkları tamamlayıcı
ve alternatif tıp, öz-etkililik düzeyi
ve TAT kullanımını etkileyen faktörleri belirlemek amacıyla
yapılmıştır.

Gereç ve Yöntem: Bu çalışma
bir üniversite hastanesinde toplamda 350 diabetes mellitus’u olan birey ile
tanımlayıcı olarak yapılmıştır. Verilerin toplanmasında bireylerin
tanıtıcı ve hastalık özelliklerini içeren kişisel anket formu, Tip 2 Diyabetlilerde Öz-Etkililik (Yeterlik)
Ölçeği ve tamamlayıcı ve alternatif tıp soru formu kullanılmıştır.

Bulgular: Çalışmaya
katılan tüm bireylerin yaş ortalaması 55.83±8.82 (min: 29-max:78 )’dir. Bireylerin
mevcut durumda TAT kullanım oranları %38.3 olduğu tespit edilmiştir. TAT
kullanan hastaların büyük çoğunluğunun bitkisel bir ürün kullandığı
saptanmıştır. Mevcut çalışmada en yaygın kullanılan ilk üç bitkisel ürün tarçın
(%44.0), limon (%22.0) ve çörek otudur (%17.0). Lojistik regresyon analizine
göre de öz-etkililik toplam puanı, açlık kan şekeri, hekim kontrolüne 6 ay
üzerinde gitmenin
TAT
kullanma durumu için önemli
belirleyiciler olduğu saptanmıştır.   







Sonuç: Tamamlayıcı
ve alternatif tedavilerden özellikle bitkisel ürünlerin yaygın olarak
kullanıldığı belirlenmiştir. Hastaların çoğunluğunun rutin kontrollerinde TAT
kullanımı ile ilgili sağlık çalışanlarını bilgilendirmedikleri saptanmıştır. Bu
açılardan diyabet yönetiminde önemli rolleri olan ve hastayla daha fazla zaman
geçiren ve doğrudan bakımlarında görev alan özellikle hemşirelerin TAT kullanım
durumunu sorgulamaları, bireylerin de sağlık çalışanlarını TAT kullanımı
konusunda bilgilendirmelerinin önemi konusunda vurgu yapmak gerekmektedir.

Kaynakça

  • 1. International Council of Nurses (ICN). Delivering Quality, Servering Communities: Nurses Leading Chronic Care. Geneva, Switzerland. 2010. Available at: http://www.icn.ch/publications/2010-delivering-quality-serving-communities-nurses-leading-chronic-care, 2010 (accessed date: 06.04.2018).
  • 2. World Health Organization (WHO). 2010. Global Status Report on Noncommunicable Diseases. Available at: www.who.int/nmh/publications/ncd_report_full_en.pdf (accessed date: 04.04.2018).
  • 3. International Diabetes Federation (IDF). 2013. Diabetes Atlas. 6th edition, Brussels, Belgium. Available at: http://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf (accessed date: 04.04.2018).
  • 4. American Diabetes Association (ADA). Standards of medical care in diabetes. Diabetes Care. 2017;40:1-135.
  • 5. Pandey A, Tripathi P, Pandey R, Srivatava R, Goswami S. Alternative therapies useful in the management of diabetes: A systematic review. J Pharm Bioallied Sci. 2011;3: 504-12.
  • 6. Hasan SS, Ahgmed SI, Bukhari NI, W.C. Wei Loon. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics. Complement Ther Clin Pract. 2009;15:152-7.
  • 7. Atwine F, Hultsjö S, Albin B, Hjelm K. Health-care seeking behaviour and the use of traditional medicine among persons with type 2 diabetes in south-western Uganda: a study of focus group interviews. Pan Afr Med J. 2015;29:76.
  • 8. Ryan EA, Pick ME, Marceu C. Use of alternative medicines in diabetes mellitus. Diabet Med. 2000;18:242-5.
  • 9. Hasani-Ranjbar S, Zahedi HS, Abdollahi M, Larijani B. Trends in publication of evidence-based Traditional Iranian medicine in endocrinology and metabolic disorders. J Diabetes Metab Disord. 2013;12:49.
  • 10. İnanç N, Çiçek B, Şahin H, Bayat M, Tasci S. Use of Herbs by the Patients with Diabetes in Kayseri. Pakistan Journal of Nutrition. 2007;6:310-2.
  • 11. Ceylan S, Azal Ö, Taşlipinar A, Türker T, Açikel CH, Gülec M. Complementary and alternative medicine use among Turkish diabetes patients. Complement Ther Med. 2009;17:78-83.
  • 12. Oksel E, Şişman FN. Complementary and alternative therapy method that patients’ use in diabetes mellitus. Journal of Ege University Nursing Faculty. 2009;25:27-36 (In Turkish)
  • 13. Küçükgüçlü Ö, Kızılcı S, Mert H, Uğur Ö, Büyükkaya Besen D, Ünsal E. Complememntary and alternative medicine use among people with diabetes in Turkey. Western Journal of Nursing Research. 2012;34: 902-916.
  • 14. Kaynak İ, Polat Ü. Diabetes mellitus’lu hastaların tamamlayıcı ve alternatif tedavileri kullanma durumları ve diyabet tutumları ile ilişkisi. Genel Tıp Dergisi. 2017;27:56-64. (In Turkish)
  • 15. Villa-Caballero L, Morello CM, Chynoweth M, Prieto-Rosinol A, Polonsky WH, Palinkas LA, Edelman SV. Ethnic differences in complementary and alternative medicine use among patients with diabetes. Complement Ther Med. 2010;18:241-8.
  • 16. Manya K, Cahmpion B, Dunnig T. The use of complementary and alternative medicine among people living with diabetes in Sydney. BMC Complement and Altern Med. 2012;12:2-5.
  • 17. Mohamed H, Abdin J, Al lenjawi B, Al Hamadini Z, Schlogl JM. Use of complementary and alternative medicine among patients with type 2 diabetes mellitus in a newly developing country: a cross-sectional study in Qatar. Int J Clin Resh Trial. 2016;2:106.
  • 18. Ching SM, Zakaria ZA, Paimin F, Jalalian M. Complementary alternative medicine use among patients with type 2 diabetes mellitus in the primary care setting: a cross-sectional study in Malaysia. BMC Complement Altern Med. 2013;13:148-53.
  • 19. Azizi-Fini I, Adib-Hajbagbery M, Gharehbogh Z. Herbal medicine use among patients with type 2 diabetes in Kashan, Iran, 2015. Eur J Integr Med. 2016;8:570-5.
  • 20. Sheikhrabori A, Dehghan M, Ghaedi F, Khademi GR. Complementary and alternative medicine usage and ıts determinant factors among diabetic patients: an Iranian case. Journal of Evidence-Based Complementary & Alternative Medicine. 2017;22:449-54.
  • 21. Chang H, Wallis M, Tiralongo E. Use of complementary and alternative medicine among people living with diabetes: literature review. J Adv Nurs. 2007;58:307-19.
  • 22. Bell RA, Suerken CK, Grzywacz JG, Lang W, Quandt SA, Arcury TA. Complementary and alternative medicine use among adults with diabetes in the United States. Altern Ther Health Med. 2006;12:16-22.
  • 23. Wazaify M, Afifi FU, El-Khateeb M, Ajlouni K. Complementary and alternative medicine use among Jordanian patients with diabetes. Complement Ther Clin Pract 2011;17:71-5.
  • 24. Redding CA, Rossi JS, Rossi SR, Velicer WF, Prochaska JO. Health behavior models. The International Electronic Journal of Health Education. 2000;3:180-93.
  • 25. Al-Khawaldeh OA, Al-Hassan MA, Froelicher ES. Self-efficacy, self-management, and glycemic control in adults with type 2 diabetes mellitus. J Diabetes Complications 2012;26:10-6.
  • 26. Gao J, Wang J, Zheng P, Haardörfer R, Kegler MC, Zhu Y, Fu H. Effects of self-care, self-efficacy, social support on glycemic control in adults with type 2 diabetes. BMC Fam Pract. 2013;14:66-72.
  • 27. Walker RJ, Smalls BL, Hernandez-Tejada MA, Campbell JA, Egede LE. Effect of diabetes self-efficacy on glycemic control, medication adherence, self-care behaviors, and quality of life in a predominantly low-income, minority population. Ethn Dis. 2014;24:349-55.
  • 28. Lwanga SK, Lemeshow S. Sample Size Determinationa in Health Studies-A practical Manuel, World Health Organization, Geneva. 1991.
  • 29. Van der Bijl J, Van Poelgeest-Eeltink A, Shortridge-Baggett L. The psychometric properties of the diabetes management self-efficacy scale for patients with type 2 diabetes mellitus. J Adv Nurs. 1999;30:352-9.
  • 30. Kara M, van der Bijl JJ, Shortridge-Bagget LM, Astı T, Erguney S. Cross-cultural adaptation of the diabetes management self-efficacy scale for patients with type 2 diabetes mellitus: Scale development. Int J Nurs Stud. 2006;43:611-21.
  • 31. N. Baharom, S.S. Azhar, A.B. Rotina. Prevalence of complementary alternative medicine use among patients with type ıı diabetes in Negeri Sembilan, Malaysia. Medicine & Health. 2016;11:257-66.
  • 32. Aydin S, Bozkaya AO, Mazicioglu M, Gemalmaz A. Özçakir A, Öztürk A. What influences herbal medicine use? Prevalence and related factors. Turk J Med Sci. 2008;38:455-63.
  • 33. Ali BAM, Mahfouz MS. Herbal medicine use among patients with type 2 diabetes in North Sudan. Ann Res Rev Biol. 2014;4:1827-38.
  • 34. Tackett KL, Jones MC. Complementary and alternative medicine for the treatment of diabetes. J of Pharmacy Practice. 2009;22:546-52.
  • 35. Posadzki P, Watson LK, Ernst E. Adverse effects of herbal medicines: an overview of systematic reviews. Clinical Medicine. 2013;13:7-12.
  • 36. Bahmani M, Zargaran A, Rafieian-Kopaei M, Kourosh S. Ethnobotanical study of medicinal plants used in the management of diabetes mellitus in the Urmia, Northwest Iran. Asian Pac J Trop Med. 2014;7(Suppl 1):S348-54.
  • 37. Bnouham M, Merhfour FZ, Ziyyat A, Mekhfi H, Aziz M, Legssyer A. Antihyperglycemic activity of the aqueous extract of Urtica. Fitoterapia.2003;74:677-81.
  • 38. Farzami B, Ahmadvand D, Vardasbi S, Majin FJ, Khaghani SH. Induction of insulin secretion by a component of Urticadioica leave extract in perifused Islets of Langerhans and its in vivo effects in normal and streptozotocin diabetic rats. J Ethnopharmacol. 2003;89:47-53.
  • 39. Ahangarpour A, Mohammmadian M, Dianat M. Antidiabetic effect of hydroalcholic urtica dioica leaf extract in male rats with fructose-ınduced ınsulin resistance. Iran J Med Sci. 2012;37:181-6.
  • 40. Kan J, Velliquette RA, Grann K, Burns CR, Scholten J, F. Q. Tian, Zhang, M. Gui. A novel botanical formula prevents diabetes by improving insulin resistance. BMC Complement Altern Med. 2017;17:352. 41. Khalaf AJ, Whitford DL. The use of complementary and alternative medicine by patients with diabetes mellitus in Bahrain:a cross-sectional study. BMC Complement and Altern Med. 2010;10:35.
  • 42. Ogbera AO, Dada O, Adeleye F, Jewo PI. Complementary and alternative medicine use in diabetes mellitus. WAJM 2010;29:158-162.
  • 43. Bradley R, Sherman KJ, Catz S, Calabrese C, Jordan L, Grothaus L, Cherkin DC. Survey of CAM interest, self-care, and satisfaction with health care for type 2 diabetes at group health cooperative. BMC Complement Altern Med. 2011;11:121.

Complementary and alternative medicine use and self-efficacy level in Turkish adults with type 2 diabetes mellitus

Yıl 2019, Cilt: 44 Sayı: 2, 309 - 318, 30.06.2019
https://doi.org/10.17826/cumj.441296

Öz

Purpose:This study was conducted to determine the complementary and
alternative medicine used by individuals with type 2 diabetes mellitus for
blood glucose control as well as their self-efficacy level and the factors
affecting the use of CAM. 

Materials and Methods:This descriptive study was conducted with a total of 350
individuals with diabetes mellitus in a university hospital.
In order to collect the data,
Personal information form including descriptive and disease characteristics of
the individuals, Self-efficacy Scale for patients with Type 2 Diabetes, and the
complementary and alternative medicine questionnaire were used.  

Results:The average age of all individuals participated in the study
was 55.83±8.82 (min: 29-max:78).
The rate of current CAM use of the patients was 38.3%.
According to the logistic regression analysis, self-efficacy total score,
fasting blood glucose, and going to physician control after 6 months were found
to be the important determinants for the use of CAM. 

Conclusion:Especially herbal products from the complementary and
alternative medicine methods were determined to be commonly used.
It was also determined that the
majority of the patients did not inform the healthcare professionals about the
use of CAM during their routine controls.
In this respect, especially the
nurses, who have important roles in diabetes management, spend more time with
the patients, and involve directly in their care, should question the use of
CAM and the importance of informing the healthcare professionals by the
individuals about the use of CAM should be emphasized.


Kaynakça

  • 1. International Council of Nurses (ICN). Delivering Quality, Servering Communities: Nurses Leading Chronic Care. Geneva, Switzerland. 2010. Available at: http://www.icn.ch/publications/2010-delivering-quality-serving-communities-nurses-leading-chronic-care, 2010 (accessed date: 06.04.2018).
  • 2. World Health Organization (WHO). 2010. Global Status Report on Noncommunicable Diseases. Available at: www.who.int/nmh/publications/ncd_report_full_en.pdf (accessed date: 04.04.2018).
  • 3. International Diabetes Federation (IDF). 2013. Diabetes Atlas. 6th edition, Brussels, Belgium. Available at: http://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf (accessed date: 04.04.2018).
  • 4. American Diabetes Association (ADA). Standards of medical care in diabetes. Diabetes Care. 2017;40:1-135.
  • 5. Pandey A, Tripathi P, Pandey R, Srivatava R, Goswami S. Alternative therapies useful in the management of diabetes: A systematic review. J Pharm Bioallied Sci. 2011;3: 504-12.
  • 6. Hasan SS, Ahgmed SI, Bukhari NI, W.C. Wei Loon. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics. Complement Ther Clin Pract. 2009;15:152-7.
  • 7. Atwine F, Hultsjö S, Albin B, Hjelm K. Health-care seeking behaviour and the use of traditional medicine among persons with type 2 diabetes in south-western Uganda: a study of focus group interviews. Pan Afr Med J. 2015;29:76.
  • 8. Ryan EA, Pick ME, Marceu C. Use of alternative medicines in diabetes mellitus. Diabet Med. 2000;18:242-5.
  • 9. Hasani-Ranjbar S, Zahedi HS, Abdollahi M, Larijani B. Trends in publication of evidence-based Traditional Iranian medicine in endocrinology and metabolic disorders. J Diabetes Metab Disord. 2013;12:49.
  • 10. İnanç N, Çiçek B, Şahin H, Bayat M, Tasci S. Use of Herbs by the Patients with Diabetes in Kayseri. Pakistan Journal of Nutrition. 2007;6:310-2.
  • 11. Ceylan S, Azal Ö, Taşlipinar A, Türker T, Açikel CH, Gülec M. Complementary and alternative medicine use among Turkish diabetes patients. Complement Ther Med. 2009;17:78-83.
  • 12. Oksel E, Şişman FN. Complementary and alternative therapy method that patients’ use in diabetes mellitus. Journal of Ege University Nursing Faculty. 2009;25:27-36 (In Turkish)
  • 13. Küçükgüçlü Ö, Kızılcı S, Mert H, Uğur Ö, Büyükkaya Besen D, Ünsal E. Complememntary and alternative medicine use among people with diabetes in Turkey. Western Journal of Nursing Research. 2012;34: 902-916.
  • 14. Kaynak İ, Polat Ü. Diabetes mellitus’lu hastaların tamamlayıcı ve alternatif tedavileri kullanma durumları ve diyabet tutumları ile ilişkisi. Genel Tıp Dergisi. 2017;27:56-64. (In Turkish)
  • 15. Villa-Caballero L, Morello CM, Chynoweth M, Prieto-Rosinol A, Polonsky WH, Palinkas LA, Edelman SV. Ethnic differences in complementary and alternative medicine use among patients with diabetes. Complement Ther Med. 2010;18:241-8.
  • 16. Manya K, Cahmpion B, Dunnig T. The use of complementary and alternative medicine among people living with diabetes in Sydney. BMC Complement and Altern Med. 2012;12:2-5.
  • 17. Mohamed H, Abdin J, Al lenjawi B, Al Hamadini Z, Schlogl JM. Use of complementary and alternative medicine among patients with type 2 diabetes mellitus in a newly developing country: a cross-sectional study in Qatar. Int J Clin Resh Trial. 2016;2:106.
  • 18. Ching SM, Zakaria ZA, Paimin F, Jalalian M. Complementary alternative medicine use among patients with type 2 diabetes mellitus in the primary care setting: a cross-sectional study in Malaysia. BMC Complement Altern Med. 2013;13:148-53.
  • 19. Azizi-Fini I, Adib-Hajbagbery M, Gharehbogh Z. Herbal medicine use among patients with type 2 diabetes in Kashan, Iran, 2015. Eur J Integr Med. 2016;8:570-5.
  • 20. Sheikhrabori A, Dehghan M, Ghaedi F, Khademi GR. Complementary and alternative medicine usage and ıts determinant factors among diabetic patients: an Iranian case. Journal of Evidence-Based Complementary & Alternative Medicine. 2017;22:449-54.
  • 21. Chang H, Wallis M, Tiralongo E. Use of complementary and alternative medicine among people living with diabetes: literature review. J Adv Nurs. 2007;58:307-19.
  • 22. Bell RA, Suerken CK, Grzywacz JG, Lang W, Quandt SA, Arcury TA. Complementary and alternative medicine use among adults with diabetes in the United States. Altern Ther Health Med. 2006;12:16-22.
  • 23. Wazaify M, Afifi FU, El-Khateeb M, Ajlouni K. Complementary and alternative medicine use among Jordanian patients with diabetes. Complement Ther Clin Pract 2011;17:71-5.
  • 24. Redding CA, Rossi JS, Rossi SR, Velicer WF, Prochaska JO. Health behavior models. The International Electronic Journal of Health Education. 2000;3:180-93.
  • 25. Al-Khawaldeh OA, Al-Hassan MA, Froelicher ES. Self-efficacy, self-management, and glycemic control in adults with type 2 diabetes mellitus. J Diabetes Complications 2012;26:10-6.
  • 26. Gao J, Wang J, Zheng P, Haardörfer R, Kegler MC, Zhu Y, Fu H. Effects of self-care, self-efficacy, social support on glycemic control in adults with type 2 diabetes. BMC Fam Pract. 2013;14:66-72.
  • 27. Walker RJ, Smalls BL, Hernandez-Tejada MA, Campbell JA, Egede LE. Effect of diabetes self-efficacy on glycemic control, medication adherence, self-care behaviors, and quality of life in a predominantly low-income, minority population. Ethn Dis. 2014;24:349-55.
  • 28. Lwanga SK, Lemeshow S. Sample Size Determinationa in Health Studies-A practical Manuel, World Health Organization, Geneva. 1991.
  • 29. Van der Bijl J, Van Poelgeest-Eeltink A, Shortridge-Baggett L. The psychometric properties of the diabetes management self-efficacy scale for patients with type 2 diabetes mellitus. J Adv Nurs. 1999;30:352-9.
  • 30. Kara M, van der Bijl JJ, Shortridge-Bagget LM, Astı T, Erguney S. Cross-cultural adaptation of the diabetes management self-efficacy scale for patients with type 2 diabetes mellitus: Scale development. Int J Nurs Stud. 2006;43:611-21.
  • 31. N. Baharom, S.S. Azhar, A.B. Rotina. Prevalence of complementary alternative medicine use among patients with type ıı diabetes in Negeri Sembilan, Malaysia. Medicine & Health. 2016;11:257-66.
  • 32. Aydin S, Bozkaya AO, Mazicioglu M, Gemalmaz A. Özçakir A, Öztürk A. What influences herbal medicine use? Prevalence and related factors. Turk J Med Sci. 2008;38:455-63.
  • 33. Ali BAM, Mahfouz MS. Herbal medicine use among patients with type 2 diabetes in North Sudan. Ann Res Rev Biol. 2014;4:1827-38.
  • 34. Tackett KL, Jones MC. Complementary and alternative medicine for the treatment of diabetes. J of Pharmacy Practice. 2009;22:546-52.
  • 35. Posadzki P, Watson LK, Ernst E. Adverse effects of herbal medicines: an overview of systematic reviews. Clinical Medicine. 2013;13:7-12.
  • 36. Bahmani M, Zargaran A, Rafieian-Kopaei M, Kourosh S. Ethnobotanical study of medicinal plants used in the management of diabetes mellitus in the Urmia, Northwest Iran. Asian Pac J Trop Med. 2014;7(Suppl 1):S348-54.
  • 37. Bnouham M, Merhfour FZ, Ziyyat A, Mekhfi H, Aziz M, Legssyer A. Antihyperglycemic activity of the aqueous extract of Urtica. Fitoterapia.2003;74:677-81.
  • 38. Farzami B, Ahmadvand D, Vardasbi S, Majin FJ, Khaghani SH. Induction of insulin secretion by a component of Urticadioica leave extract in perifused Islets of Langerhans and its in vivo effects in normal and streptozotocin diabetic rats. J Ethnopharmacol. 2003;89:47-53.
  • 39. Ahangarpour A, Mohammmadian M, Dianat M. Antidiabetic effect of hydroalcholic urtica dioica leaf extract in male rats with fructose-ınduced ınsulin resistance. Iran J Med Sci. 2012;37:181-6.
  • 40. Kan J, Velliquette RA, Grann K, Burns CR, Scholten J, F. Q. Tian, Zhang, M. Gui. A novel botanical formula prevents diabetes by improving insulin resistance. BMC Complement Altern Med. 2017;17:352. 41. Khalaf AJ, Whitford DL. The use of complementary and alternative medicine by patients with diabetes mellitus in Bahrain:a cross-sectional study. BMC Complement and Altern Med. 2010;10:35.
  • 42. Ogbera AO, Dada O, Adeleye F, Jewo PI. Complementary and alternative medicine use in diabetes mellitus. WAJM 2010;29:158-162.
  • 43. Bradley R, Sherman KJ, Catz S, Calabrese C, Jordan L, Grothaus L, Cherkin DC. Survey of CAM interest, self-care, and satisfaction with health care for type 2 diabetes at group health cooperative. BMC Complement Altern Med. 2011;11:121.
Toplam 42 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Araştırma
Yazarlar

Alime Selçuk Tosun 0000-0002-4851-0910

Handan Zincir 0000-0002-1722-4647

Elif Eliş Bu kişi benim 0000-0002-3566-2317

Yayımlanma Tarihi 30 Haziran 2019
Kabul Tarihi 16 Eylül 2018
Yayımlandığı Sayı Yıl 2019 Cilt: 44 Sayı: 2

Kaynak Göster

MLA Selçuk Tosun, Alime vd. “Complementary and Alternative Medicine Use and Self-Efficacy Level in Turkish Adults With Type 2 Diabetes Mellitus”. Cukurova Medical Journal, c. 44, sy. 2, 2019, ss. 309-18, doi:10.17826/cumj.441296.